Global Fabry Disease Therapeutic Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 295107
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Fabry Disease Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Fabry Disease Therapeutic market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Fabry Disease Therapeutic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Enzyme Replacement Therapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Fabry Disease Therapeutic include Amicus therapeutics, Takeda, Genzyme-Sanofi, Protalix, and Sanofi-Aventis LLC, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Fabry Disease Therapeutic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Enzyme Replacement Therapy

Alternative therapies

Market segment by Application, can be divided into

Hospitals

Clinics

Other

Market segment by players, this report covers

Amicus therapeutics

Takeda

Genzyme-Sanofi

Protalix

Sanofi-Aventis LLC

Novartis Pharmaceuticals

Pfizer

Bristol-Myers Squibb Company

GlaxoSmithKline plc

Amgen Inc.

Teva pharmaceutical Industries Ltd.

Merc & Co.

AbbVie Inc.

Takeda Pharmaceutical Co. Ltd.

Green Cross Corp.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Fabry Disease Therapeutic product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Fabry Disease Therapeutic, with revenue, gross margin and global market share of Fabry Disease Therapeutic from 2019 to 2022.

Chapter 3, the Fabry Disease Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Fabry Disease Therapeutic market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Fabry Disease Therapeutic research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Fabry Disease Therapeutic

1.2 Classification of Fabry Disease Therapeutic by Type

1.2.1 Overview: Global Fabry Disease Therapeutic Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Fabry Disease Therapeutic Revenue Market Share by Type in 2021

1.2.3 Enzyme Replacement Therapy

1.2.4 Alternative therapies

1.3 Global Fabry Disease Therapeutic Market by Application

1.3.1 Overview: Global Fabry Disease Therapeutic Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Fabry Disease Therapeutic Market Size & Forecast

1.5 Global Fabry Disease Therapeutic Market Size and Forecast by Region

1.5.1 Global Fabry Disease Therapeutic Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Fabry Disease Therapeutic Market Size by Region, (2017-2022)

1.5.3 North America Fabry Disease Therapeutic Market Size and Prospect (2017-2028)

1.5.4 Europe Fabry Disease Therapeutic Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Fabry Disease Therapeutic Market Size and Prospect (2017-2028)

1.5.6 South America Fabry Disease Therapeutic Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Fabry Disease Therapeutic Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Fabry Disease Therapeutic Market Drivers

1.6.2 Fabry Disease Therapeutic Market Restraints

1.6.3 Fabry Disease Therapeutic Trends Analysis

2 Company Profiles

2.1 Amicus therapeutics

2.1.1 Amicus therapeutics Details

2.1.2 Amicus therapeutics Major Business

2.1.3 Amicus therapeutics Fabry Disease Therapeutic Product and Solutions

2.1.4 Amicus therapeutics Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Amicus therapeutics Recent Developments and Future Plans

2.2 Takeda

2.2.1 Takeda Details

2.2.2 Takeda Major Business

2.2.3 Takeda Fabry Disease Therapeutic Product and Solutions

2.2.4 Takeda Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Takeda Recent Developments and Future Plans

2.3 Genzyme-Sanofi

2.3.1 Genzyme-Sanofi Details

2.3.2 Genzyme-Sanofi Major Business

2.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Product and Solutions

2.3.4 Genzyme-Sanofi Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Genzyme-Sanofi Recent Developments and Future Plans

2.4 Protalix

2.4.1 Protalix Details

2.4.2 Protalix Major Business

2.4.3 Protalix Fabry Disease Therapeutic Product and Solutions

2.4.4 Protalix Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Protalix Recent Developments and Future Plans

2.5 Sanofi-Aventis LLC

2.5.1 Sanofi-Aventis LLC Details

2.5.2 Sanofi-Aventis LLC Major Business

2.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Product and Solutions

2.5.4 Sanofi-Aventis LLC Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Sanofi-Aventis LLC Recent Developments and Future Plans

2.6 Novartis Pharmaceuticals

2.6.1 Novartis Pharmaceuticals Details

2.6.2 Novartis Pharmaceuticals Major Business

2.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Product and Solutions

2.6.4 Novartis Pharmaceuticals Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Pharmaceuticals Recent Developments and Future Plans

2.7 Pfizer

2.7.1 Pfizer Details

2.7.2 Pfizer Major Business

2.7.3 Pfizer Fabry Disease Therapeutic Product and Solutions

2.7.4 Pfizer Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Pfizer Recent Developments and Future Plans

2.8 Bristol-Myers Squibb Company

2.8.1 Bristol-Myers Squibb Company Details

2.8.2 Bristol-Myers Squibb Company Major Business

2.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Product and Solutions

2.8.4 Bristol-Myers Squibb Company Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Bristol-Myers Squibb Company Recent Developments and Future Plans

2.9 GlaxoSmithKline plc

2.9.1 GlaxoSmithKline plc Details

2.9.2 GlaxoSmithKline plc Major Business

2.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Product and Solutions

2.9.4 GlaxoSmithKline plc Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.10 Amgen Inc.

2.10.1 Amgen Inc. Details

2.10.2 Amgen Inc. Major Business

2.10.3 Amgen Inc. Fabry Disease Therapeutic Product and Solutions

2.10.4 Amgen Inc. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Amgen Inc. Recent Developments and Future Plans

2.11 Teva pharmaceutical Industries Ltd.

2.11.1 Teva pharmaceutical Industries Ltd. Details

2.11.2 Teva pharmaceutical Industries Ltd. Major Business

2.11.3 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Product and Solutions

2.11.4 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Teva pharmaceutical Industries Ltd. Recent Developments and Future Plans

2.12 Merc & Co.

2.12.1 Merc & Co. Details

2.12.2 Merc & Co. Major Business

2.12.3 Merc & Co. Fabry Disease Therapeutic Product and Solutions

2.12.4 Merc & Co. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Merc & Co. Recent Developments and Future Plans

2.13 AbbVie Inc.

2.13.1 AbbVie Inc. Details

2.13.2 AbbVie Inc. Major Business

2.13.3 AbbVie Inc. Fabry Disease Therapeutic Product and Solutions

2.13.4 AbbVie Inc. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 AbbVie Inc. Recent Developments and Future Plans

2.14 Takeda Pharmaceutical Co. Ltd.

2.14.1 Takeda Pharmaceutical Co. Ltd. Details

2.14.2 Takeda Pharmaceutical Co. Ltd. Major Business

2.14.3 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Product and Solutions

2.14.4 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Takeda Pharmaceutical Co. Ltd. Recent Developments and Future Plans

2.15 Green Cross Corp.

2.15.1 Green Cross Corp. Details

2.15.2 Green Cross Corp. Major Business

2.15.3 Green Cross Corp. Fabry Disease Therapeutic Product and Solutions

2.15.4 Green Cross Corp. Fabry Disease Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Green Cross Corp. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Fabry Disease Therapeutic Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Fabry Disease Therapeutic Players Market Share in 2021

3.2.2 Top 10 Fabry Disease Therapeutic Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Fabry Disease Therapeutic Players Head Office, Products and Services Provided

3.4 Fabry Disease Therapeutic Mergers & Acquisitions

3.5 Fabry Disease Therapeutic New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Fabry Disease Therapeutic Revenue and Market Share by Type (2017-2022)

4.2 Global Fabry Disease Therapeutic Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Fabry Disease Therapeutic Revenue Market Share by Application (2017-2022)

5.2 Global Fabry Disease Therapeutic Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Fabry Disease Therapeutic Revenue by Type (2017-2028)

6.2 North America Fabry Disease Therapeutic Revenue by Application (2017-2028)

6.3 North America Fabry Disease Therapeutic Market Size by Country

6.3.1 North America Fabry Disease Therapeutic Revenue by Country (2017-2028)

6.3.2 United States Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

6.3.3 Canada Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

6.3.4 Mexico Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Fabry Disease Therapeutic Revenue by Type (2017-2028)

7.2 Europe Fabry Disease Therapeutic Revenue by Application (2017-2028)

7.3 Europe Fabry Disease Therapeutic Market Size by Country

7.3.1 Europe Fabry Disease Therapeutic Revenue by Country (2017-2028)

7.3.2 Germany Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

7.3.3 France Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

7.3.5 Russia Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

7.3.6 Italy Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Fabry Disease Therapeutic Revenue by Type (2017-2028)

8.2 Asia-Pacific Fabry Disease Therapeutic Revenue by Application (2017-2028)

8.3 Asia-Pacific Fabry Disease Therapeutic Market Size by Region

8.3.1 Asia-Pacific Fabry Disease Therapeutic Revenue by Region (2017-2028)

8.3.2 China Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8.3.3 Japan Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8.3.4 South Korea Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8.3.5 India Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

8.3.7 Australia Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Fabry Disease Therapeutic Revenue by Type (2017-2028)

9.2 South America Fabry Disease Therapeutic Revenue by Application (2017-2028)

9.3 South America Fabry Disease Therapeutic Market Size by Country

9.3.1 South America Fabry Disease Therapeutic Revenue by Country (2017-2028)

9.3.2 Brazil Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

9.3.3 Argentina Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Fabry Disease Therapeutic Revenue by Type (2017-2028)

10.2 Middle East & Africa Fabry Disease Therapeutic Revenue by Application (2017-2028)

10.3 Middle East & Africa Fabry Disease Therapeutic Market Size by Country

10.3.1 Middle East & Africa Fabry Disease Therapeutic Revenue by Country (2017-2028)

10.3.2 Turkey Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

10.3.4 UAE Fabry Disease Therapeutic Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Fabry Disease Therapeutic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Fabry Disease Therapeutic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Fabry Disease Therapeutic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Fabry Disease Therapeutic Revenue (USD Million) by Region (2017-2022)

Table 5. Global Fabry Disease Therapeutic Revenue Market Share by Region (2023-2028)

Table 6. Amicus therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Amicus therapeutics Major Business

Table 8. Amicus therapeutics Fabry Disease Therapeutic Product and Solutions

Table 9. Amicus therapeutics Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Takeda Corporate Information, Head Office, and Major Competitors

Table 11. Takeda Major Business

Table 12. Takeda Fabry Disease Therapeutic Product and Solutions

Table 13. Takeda Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Genzyme-Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Genzyme-Sanofi Major Business

Table 16. Genzyme-Sanofi Fabry Disease Therapeutic Product and Solutions

Table 17. Genzyme-Sanofi Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Protalix Corporate Information, Head Office, and Major Competitors

Table 19. Protalix Major Business

Table 20. Protalix Fabry Disease Therapeutic Product and Solutions

Table 21. Protalix Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Sanofi-Aventis LLC Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi-Aventis LLC Major Business

Table 24. Sanofi-Aventis LLC Fabry Disease Therapeutic Product and Solutions

Table 25. Sanofi-Aventis LLC Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Pharmaceuticals Major Business

Table 28. Novartis Pharmaceuticals Fabry Disease Therapeutic Product and Solutions

Table 29. Novartis Pharmaceuticals Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Pfizer Corporate Information, Head Office, and Major Competitors

Table 31. Pfizer Major Business

Table 32. Pfizer Fabry Disease Therapeutic Product and Solutions

Table 33. Pfizer Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors

Table 35. Bristol-Myers Squibb Company Major Business

Table 36. Bristol-Myers Squibb Company Fabry Disease Therapeutic Product and Solutions

Table 37. Bristol-Myers Squibb Company Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 39. GlaxoSmithKline plc Major Business

Table 40. GlaxoSmithKline plc Fabry Disease Therapeutic Product and Solutions

Table 41. GlaxoSmithKline plc Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Amgen Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Amgen Inc. Major Business

Table 44. Amgen Inc. Fabry Disease Therapeutic Product and Solutions

Table 45. Amgen Inc. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Teva pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors

Table 47. Teva pharmaceutical Industries Ltd. Major Business

Table 48. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Product and Solutions

Table 49. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Merc & Co. Corporate Information, Head Office, and Major Competitors

Table 51. Merc & Co. Major Business

Table 52. Merc & Co. Fabry Disease Therapeutic Product and Solutions

Table 53. Merc & Co. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. AbbVie Inc. Corporate Information, Head Office, and Major Competitors

Table 55. AbbVie Inc. Major Business

Table 56. AbbVie Inc. Fabry Disease Therapeutic Product and Solutions

Table 57. AbbVie Inc. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Takeda Pharmaceutical Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Takeda Pharmaceutical Co. Ltd. Major Business

Table 60. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Product and Solutions

Table 61. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Green Cross Corp. Corporate Information, Head Office, and Major Competitors

Table 63. Green Cross Corp. Major Business

Table 64. Green Cross Corp. Fabry Disease Therapeutic Product and Solutions

Table 65. Green Cross Corp. Fabry Disease Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Fabry Disease Therapeutic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Fabry Disease Therapeutic Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Fabry Disease Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Fabry Disease Therapeutic Players Head Office, Products and Services Provided

Table 70. Fabry Disease Therapeutic Mergers & Acquisitions in the Past Five Years

Table 71. Fabry Disease Therapeutic New Entrants and Expansion Plans

Table 72. Global Fabry Disease Therapeutic Revenue (USD Million) by Type (2017-2022)

Table 73. Global Fabry Disease Therapeutic Revenue Share by Type (2017-2022)

Table 74. Global Fabry Disease Therapeutic Revenue Forecast by Type (2023-2028)

Table 75. Global Fabry Disease Therapeutic Revenue by Application (2017-2022)

Table 76. Global Fabry Disease Therapeutic Revenue Forecast by Application (2023-2028)

Table 77. North America Fabry Disease Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Fabry Disease Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Fabry Disease Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Fabry Disease Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Fabry Disease Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Fabry Disease Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Fabry Disease Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Fabry Disease Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Fabry Disease Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Fabry Disease Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Fabry Disease Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Fabry Disease Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Fabry Disease Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Fabry Disease Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Fabry Disease Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Fabry Disease Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Fabry Disease Therapeutic Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Fabry Disease Therapeutic Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Fabry Disease Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Fabry Disease Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Fabry Disease Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Fabry Disease Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Fabry Disease Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Fabry Disease Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Fabry Disease Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Fabry Disease Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Fabry Disease Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Fabry Disease Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Fabry Disease Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Fabry Disease Therapeutic Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Fabry Disease Therapeutic Picture

Figure 2. Global Fabry Disease Therapeutic Revenue Market Share by Type in 2021

Figure 3. Enzyme Replacement Therapy

Figure 4. Alternative therapies

Figure 5. Fabry Disease Therapeutic Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Clinics Picture

Figure 8. Other Picture

Figure 9. Global Fabry Disease Therapeutic Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Fabry Disease Therapeutic Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Fabry Disease Therapeutic Revenue Market Share by Region (2017-2028)

Figure 12. Global Fabry Disease Therapeutic Revenue Market Share by Region in 2021

Figure 13. North America Fabry Disease Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Fabry Disease Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Fabry Disease Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Fabry Disease Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Fabry Disease Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Fabry Disease Therapeutic Market Drivers

Figure 19. Fabry Disease Therapeutic Market Restraints

Figure 20. Fabry Disease Therapeutic Market Trends

Figure 21. Amicus therapeutics Recent Developments and Future Plans

Figure 22. Takeda Recent Developments and Future Plans

Figure 23. Genzyme-Sanofi Recent Developments and Future Plans

Figure 24. Protalix Recent Developments and Future Plans

Figure 25. Sanofi-Aventis LLC Recent Developments and Future Plans

Figure 26. Novartis Pharmaceuticals Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. Bristol-Myers Squibb Company Recent Developments and Future Plans

Figure 29. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 30. Amgen Inc. Recent Developments and Future Plans

Figure 31. Teva pharmaceutical Industries Ltd. Recent Developments and Future Plans

Figure 32. Merc & Co. Recent Developments and Future Plans

Figure 33. AbbVie Inc. Recent Developments and Future Plans

Figure 34. Takeda Pharmaceutical Co. Ltd. Recent Developments and Future Plans

Figure 35. Green Cross Corp. Recent Developments and Future Plans

Figure 36. Global Fabry Disease Therapeutic Revenue Share by Players in 2021

Figure 37. Fabry Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Fabry Disease Therapeutic Revenue Market Share in 2021

Figure 39. Global Top 10 Players Fabry Disease Therapeutic Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Fabry Disease Therapeutic Revenue Share by Type in 2021

Figure 42. Global Fabry Disease Therapeutic Market Share Forecast by Type (2023-2028)

Figure 43. Global Fabry Disease Therapeutic Revenue Share by Application in 2021

Figure 44. Global Fabry Disease Therapeutic Market Share Forecast by Application (2023-2028)

Figure 45. North America Fabry Disease Therapeutic Sales Market Share by Type (2017-2028)

Figure 46. North America Fabry Disease Therapeutic Sales Market Share by Application (2017-2028)

Figure 47. North America Fabry Disease Therapeutic Revenue Market Share by Country (2017-2028)

Figure 48. United States Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Fabry Disease Therapeutic Sales Market Share by Type (2017-2028)

Figure 52. Europe Fabry Disease Therapeutic Sales Market Share by Application (2017-2028)

Figure 53. Europe Fabry Disease Therapeutic Revenue Market Share by Country (2017-2028)

Figure 54. Germany Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Fabry Disease Therapeutic Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Fabry Disease Therapeutic Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Fabry Disease Therapeutic Revenue Market Share by Region (2017-2028)

Figure 62. China Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Fabry Disease Therapeutic Sales Market Share by Type (2017-2028)

Figure 69. South America Fabry Disease Therapeutic Sales Market Share by Application (2017-2028)

Figure 70. South America Fabry Disease Therapeutic Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Fabry Disease Therapeutic Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Fabry Disease Therapeutic Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Fabry Disease Therapeutic Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Fabry Disease Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz